Page last updated: 2024-08-05 13:04:05
peptidyl amide
A peptide that has a carbamoyl group at the C-terminus.
ChEBI ID: 15722
Members (4)
Member | Definition | Role |
---|---|---|
forapin | A 26-membered polypeptide consisting of Gly, Ile, Gly, Ala, Val, Leu, Lys, Val, Leu, Thr, Thr, Gly, Leu, Pro, Ala, Leu, Ile, Ser, Trp, Ile, Lys, Arg, Lys, Arg, Gln and Gln-NH2 residues joined in sequence. It is the principal active component of bee venom. | melittin |
mastoparan | A member of the class of mastopyrans that is a 14-amino acid polypeptide comprising isoleucyl, asparaginyl, leucyl, lysyl, alanyl, leucyl, alanyl, alanyl, leucyl, alanyl, lysyl, lysyl, isoleucyl, and leucinamide residues coupled in sequence. It is the major active component of the venom of the vespid wasp, Vespula lewisii and causes degranulation of mast cells. | mastoparan |
mastoparan x | A member of the class of mastopyrans that is a 14-amino acid polypeptide comprising isoleucyl, asparaginyl, tryptophyl, lysyl, glycyl, isoleucyl, alanyl, alanyl, methionyl, alanyl, lysyl, lysyl, leucyl, and leucinamide residues coupled in sequence. It is the major active component of the venom of the hornet Vespa velutina and causes degranulation of mast cells. It exhibits antimicrobial activity against both Gram-positive and -negative bacteria as well as haemolytic activity on chicken, human and sheep erythrocytes. | mastoparan-V |
tetragastrin | A tetrapeptide composed of L-tryptophan, L-methione, L-aspartic acid and L-phenylalaninamide residues joined in sequence. | tetragastrin |
Research
Studies (1,147)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 218 (19.01) | 18.7374 |
1990's | 474 (41.33) | 18.2507 |
2000's | 269 (23.45) | 29.6817 |
2010's | 148 (12.90) | 24.3611 |
2020's | 38 (3.31) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 73 (6.05%) | 5.53% |
Reviews | 43 (3.56%) | 6.00% |
Case Studies | 3 (0.25%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 1,088 (90.14%) | 84.16% |